Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome

BACKGROUND: Cripto-1 (CR-1) has been reported to be involved in the development of several human cancers. The potential role of CR-1 in clear cell renal cell carcinoma (ccRCC) is still not clear. METHODS: CR-1 expression was evaluated in ccRCC tissues by Real-time quantitative PCR, Western blot and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yi-Jun, Chen, Song-Ning, Chen, Wei-Guang, Wu, Geng-Qing, Liao, Yun-Feng, Xu, Jian-Bin, Tang, Hao, Yang, Shui-Hua, He, Shui-Yong, Luo, Yun-Fei, Wu, Zhi-Hui, Huang, Hai-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712621/
https://www.ncbi.nlm.nih.gov/pubmed/31455359
http://dx.doi.org/10.1186/s13046-019-1386-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712621/
https://www.ncbi.nlm.nih.gov/pubmed/31455359
http://dx.doi.org/10.1186/s13046-019-1386-6

Ejemplares similares